Authors:Auris Huen, University of Texas MD Anderson Cancer CenterBradley M. Haverkos, University of ColoradoJasmine Zain, City Hope Comprehensive Cancer CenterRamchandren Radhakrishnan, University of TennesseeMary Lechowicz, Emory UniversitySumana Devata, University of MichiganNeil J. Korman, Case Western Reserve UniversityLauren Pinter-Brown, University of California IrvineYasuhiro Oki, University of Texas MD Anderson Cancer CenterPrajak J. Barde, Rhizen Pharmaceut SAAjit Nair, Rhizen Pharmaceut SAKasi Viswanath Routhu, Rhizen Pharmaceut SASrikant Viswanadha, Rhizen Pharmaceut SASwaroop Vakkalanka, Rhizen Pharmaceut SASwaminathan P. Iyer, University of Texas MD Anderson Cancer Center
Authors:Jatin J. Shah, University of Texas MD Anderson Cancer CenterJonathan Kaufman, Emory UniversityJeffrey A. Zonder, Wayne State UniversityAdam D. Cohen, Fox Chase Cancer CenterWilliam I. Bensinger, Fred Hutchinson Cancer Research CenterBrandi Hilder, Array BioPharma IncSelena Rush, Array BioPharma IncDuncan Walker, Array BioPharma IncBrian Tunquist, Array BioPharma IncKevin Litwiler, Array BioPharma IncMieke Ptaszynski, Array BioPharma IncRobert Z. Orlowski, University of Texas MD Anderson Cancer CenterSagar Lonial, Emory University